An Open-Label, Multi-Center, Rollover Study to Provide Continued Treatment Access for Participants Enrolled in Studies of BXQ-350

Grants and Contracts Details

StatusActive
Effective start/end date5/27/203/12/25

Funding

  • CTI Clinical Trial and Consulting Services: $79,353.00